GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,554
Funds Holding Change
-13
Funds Holding Growth
-0.5%
Value
$488B
Holding in Top 10
610
Top 10 Change
-6
Top 10 Growth
-1%
Value Growth
-7%
New
89
Increased
1,157
Reduced
1,093
Closed
82
Capital Inflow
$27.6B
Capital Outflow
$20.2B
Net Capital Flow
+$7.4B
Capital Flow Change
+$8.56B
Calls
$6.78B
Puts
$6.13B
Net Calls
+$644M
Put/Call Ratio
0.9